Companies receiving letters include Kin Meds, GoodGirlRx, WeightCare, and PharmaZee
NICE guidelines (NG28) support the use of GLP-1 receptor agonists for type 2 diabetes when glycaemic targets are not achieved with other therapies, and for weight management in specific circumstances (TA875 for Wegovy, TA664 for Saxenda)
As part of this program, members are expected to take accountability, which includes making changes to their diet and incorporating exercise
Prices typically range $189/mo month-to-month, or from $149/mo on the 6-month plan for compounded semaglutide or tirzepatide injections
Tracking Your Progress As you taper, its important to watch for specific signs that indicate how well the process is going
Join the list below to help shape the launch and get first access